Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC)

Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Discussion

Thursday, September 28, 2023

9:30 AM - 9:45 AM ET

Moderator(s)

Cathy Eng, MD, FACP, FASCO

Vanderbilt-Ingram Cancer Center
MD Anderson Cancer Center
David H. Ilson, MD, PhD

Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center

Panelist(s)

Anup Kasi, MD, MPH

Kansas University Cancer Center
Yelena Y. Janjigian, MD

Memorial Sloan Kettering Cancer Center